I hosted the RESI Redefining Early Stage Investments at MaRS in Toronto on June 23rd.  This event was a partnership with LSN of Boston and brought together 250 international investors in partnership with 250 early stage fundraising CEOs.  Over 800 investment meetings took place that day and it is estimated it represented almost $300 M in investment assets in the room.

This was a great event to profile Canadian Health & Life Sciences to the world and a meaningful way to introduce them to much needed investment for growth and scaling of their important innovations.  This was an undertaking near and dear to my heart and my last official function as Managing Director of Health Innovation and Ventures at MaRS.